Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 44(11): 4567-71, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19615789

ABSTRACT

3Beta,11beta-dihydroxy-9alpha-fluor-5alpha-androstane-17-one (2), 3beta-acetoxy-9alpha-fluor-11beta-hydroxy-5alpha-androstane-17-one (3), 3beta-acetoxy-9alpha-fluor-11beta,17beta-dihydroxy-5alpha-androstane (4), 3beta,17beta-diacetoxy-9alpha-fluor-11beta-hydroxy-5alpha-androstane (5), 3beta-acetoxy-9alpha-fluor-11beta-hydroxy-5alpha-androstane 17beta-propionate (6), 3beta-acetoxy-9alpha-fluor-11beta-hydroxy-5alpha-androstane 17beta-enanthate (7), 3beta-acetoxy-9alpha-fluor-11beta-hydroxy-5alpha-androstane 17beta-isobutyrate (8) were synthesized in the present study. Compounds 2 and 8 exhibited higher anabolic activity than the rest of the synthesized compounds. The structure of all these newly synthesized compounds was confirmed by analytic spectral data (mass, (1)H NMR and (13)C NMR).


Subject(s)
Anabolic Agents/chemistry , Anabolic Agents/pharmacology , Androgens/chemistry , Androgens/pharmacology , Androstanes/chemistry , Androstanes/pharmacology , Anabolic Agents/chemical synthesis , Androgens/chemical synthesis , Androstanes/chemical synthesis , Animals , Fluorine/chemistry , Fluorine/pharmacology , Male , Muscles/drug effects , Organ Size/drug effects , Prostate/drug effects , Rats , Rats, Wistar , Seminal Vesicles/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...